10015
0
Posted on Jul 25, 2004, 10 a.m.
By Bill Freeman
Wired notes that restrictive legislation, politics and controversy have scared away venture capital from investing in stem cell research. Private for-profit investors are notoriously risk-averse, and the present polical environment makes stem cell investment look like a very risky bet. "But while they may not be investing in the companies themselves, venture capitalists haven't completely abandoned stem-cell work.
Wired notes that restrictive legislation, politics and controversy have scared away venture capital from investing in stem cell research. Private for-profit investors are notoriously risk-averse, and the present polical environment makes stem cell investment look like a very risky bet. "But while they may not be investing in the companies themselves, venture capitalists haven't completely abandoned stem-cell work. Instead, they're contributing through efforts like the California Stem Cell Initiative. If the initiative passes in November, the political climate for embryonic stem-cell research will likely be more agreeable, at least in California."
View the Article Under Discussion: http://www.wired.com/news/medtech/0,1286,64302,00.html?tw=wn_tophead_1
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/
View the Article Under Discussion: http://www.wired.com/news/medtech/0,1286,64302,00.html?tw=wn_tophead_1
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/
